Even temporary MYC inhibition appears to halt tumor induction and ectopic proliferation, suggesting that strategies for MYC inhibition have theranostic potential for tackling MYC-driven cancers; however, direct MYC inhibition is challenging, as the protein lacks an active binding site for small molecules. The gene discussed is MYC; the disease is neoplasm.